This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Atogen Co., Ltd. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Innovations by Sung Hoon Im in Antimicrobial Treatments
Introduction
Sung Hoon Im is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of microbiology, particularly in the development of novel strains for medical applications. With a total of 3 patents, his work focuses on innovative solutions for health-related issues.
Latest Patents
Among his latest patents are Lactobacillus plantarum strains ATG-K2, ATG-K6, and ATG-K8. These strains are proposed for use in compositions aimed at preventing or treating vaginitis. The strains exhibit excellent antimicrobial effects against various pathogenic strains, making them suitable for treating bacterial vaginosis and vaginal candidiasis. Additionally, they can be utilized as functional health foods to prevent or ameliorate these diseases.
Career Highlights
Sung Hoon Im is associated with Atogen Co., Ltd., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on women's health and the treatment of related conditions.
Collaborations
He collaborates with notable colleagues, including Bo Ram Beck and Gun Seok Park, to further enhance the research and development of his innovative solutions.
Conclusion
Sung Hoon Im's contributions to antimicrobial treatments through his patented strains represent a significant advancement in the field of health sciences. His ongoing work promises to improve the quality of life for many individuals facing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile